110
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Assessment of Direct Costs of Admission Due to Presumed Microbial Keratitis in a Tertiary Referral Hospital in Thailand: A 7-Year Retrospective Study

ORCID Icon, , , , , ORCID Icon & show all
Pages 2845-2860 | Received 08 Jun 2023, Accepted 22 Sep 2023, Published online: 29 Sep 2023

References

  • Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Heal. 2017;5(12):e1221–34. doi:10.1016/S2214-109X(17)30393-5
  • Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye. 2021;35(4):1084–1101. doi:10.1038/s41433-020-01339-3
  • Song X, Xie L, Tan X, et al. A multi-center, cross-sectional study on the burden of infectious keratitis in China. PLoS One. 2014;9(12):e113843. doi:10.1371/journal.pone.0113843
  • Khor WB, Prajna VN, Garg P, et al. The Asia cornea society infectious keratitis Study: a prospective multicenter study of infectious keratitis in Asia. Am J Ophthalmol. 2018;195:161–170. doi:10.1016/j.ajo.2018.07.040
  • Ung L, Bispo PJM, Shanbhag SS, et al. The persistent dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol. 2019;64(3):255–271. doi:10.1016/j.survophthal.2018.12.003
  • Lin A, Rhee MK, Akpek EK, et al. Bacterial keratitis preferred practice pattern. Ophthalmology. 2019;126(1):1–55. doi:10.1016/j.ophtha.2018.10.018
  • Tananuvat N, Suwanniponth M. Microbial keratitis in Thailand: a survey of common practice patterns. J Med Assoc Thai. 2008;91(3):316–322.
  • World Health Organization. Global spending on health: weathering the storm 2020. Working paper; 2020.
  • Bourne RRA, Steinmetz JD, Flaxman S, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study. Lancet Glob Heal. 2021;9(2):e130–43. doi:10.1016/S2214-109X(20)30425-3
  • Moussa G, Hodson J, Gooch N, et al. Calculating the economic burden of presumed microbial keratitis admissions at a tertiary referral centre in the UK. Eye. 2021;35(8):2146–2154. doi:10.1038/s41433-020-01333-9
  • Koh YY, Sun CC, Hsiao CH. Epidemiology and the estimated burden of microbial keratitis on the health care system in Taiwan: a 14-year population-based study. Am J Ophthalmol. 2020;220:152–159. doi:10.1016/j.ajo.2020.07.026
  • Prajna VN, Nirmalan PK, Saravanan S, Srinivasan M. Economic analysis of corneal ulcers in South India. Cornea. 2007;26(2):119–122. doi:10.1097/ICO.0b013e31802b36dc
  • Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis: predisposing factors and morbidity. Ophthalmology. 2006;113(1):109–116. doi:10.1016/j.ophtha.2005.08.013
  • Kampitak K, Patrasuwan S, Kongsomboon K. Cost evaluation of corneal ulcer treatment. J Med Assoc Thail. 2013;96(4):456–459.
  • Bourne RRA, Steinmetz JD, Saylan M, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Heal. 2021;9(2):e144–60. doi:10.1016/S2214-109X(20)30489-7
  • Gurnani B, Kaur K. Bacterial keratitis. In: StatPearls. StatPearls Publishing LLC; 2022.
  • Keay L, Edwards K, Dart J, Stapleton F. Grading contact lens-related microbial keratitis: relevance to disease burden. Optom Vis Sci. 2008;85(7):531–537. doi:10.1097/OPX.0b013e31817dba2e
  • Verhelst D, Koppen C, Van Looveren J, Meheus A, Tassignon MJ. Clinical, epidemiological and cost aspects of contact lens related infectious keratitis in Belgium: results of a seven-year retrospective study. Bull Soc Belge Ophtalmol. 2005;297:7–15.
  • Roth AR, Lazris A. Benefits of avoiding unnecessary medical care during the COVID-19 pandemic. Am Fam Physician. 2021;103(10):584–585.
  • Portela MC, Cristina C, Pereira DA, Maria S, Lima L. Patterns of hospital utilization in the unified health system in six Brazilian capitals: comparison between the year before and the first six first months of the COVID-19 pandemic. BMC Health Serv Res. 2021;21:1–13. doi:10.1186/s12913-020-05996-8
  • Bhatt AS, Moscone A, Mcelrath EE, Varshney AS. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J Am Coll Cardiol. 2020;76(January):280–288. doi:10.1016/j.jacc.2020.05.038
  • Caminiti C, Meschi T, Braglia L, et al. Reducing unnecessary hospital days to improve quality of care through physician accountability: a cluster randomised trial. BMC Health Serv Res. 2013;13(1):1. doi:10.1186/1472-6963-13-14
  • Ballouz D, Maganti N, Tuohy M, Errickson J, Woodward MA. Medication burden for patients with bacterial keratitis. Cornea. 2019;38(8):933–937. doi:10.1097/ICO.0000000000001942
  • Boonpasart S, Puangsricharern V, Jittpoonkusol T, Kasetsuwan N, Pariyakanok L. Infectious keratitis at King Chulalongkorn Memorial Hospital: a-12-year retrospective study of 391 cases. J Med Assoc Thail. 2002;85(1):217–230.
  • Ting DSJ, Settle C, Morgan SJ, Baylis O, Ghosh S. A 10-year analysis of microbiological profiles of microbial keratitis: the North East England Study. Eye. 2018;32(8):1416–1417. doi:10.1038/s41433-018-0085-4
  • Peng MY, Cevallos V, McLeod SD, Lietman TM, Rose-Nussbaumer J. Bacterial keratitis: isolated organisms and antibiotic resistance patterns in San Francisco. Cornea. 2018;37(1):84–87. doi:10.1097/ICO.0000000000001417
  • Kaliamurthy J, Kalavathy CM, Parmar P, Nelson Jesudasan CA, Thomas PA. Spectrum of bacterial keratitis at a tertiary eye care centre in India. Biomed Res Int. 2013;2013:1–8. doi:10.1155/2013/181564
  • Jongkhajornpong P, Nimworaphan J, Lekhanont K, Chuckpaiwong V, Rattanasiri S. Predicting factors and prediction model for discriminating between fungal infection and bacterial infection in severe microbial keratitis. PLoS One. 2019;14(3):e0214076. doi:10.1371/journal.pone.0214076
  • Günaydin NT, Kandemir B, Gokce GD, Özen MC, Gün RD, Haciseyitoğlu D. Comparison of culture-positive and culture-negative severe infectious keratitis leading to hospitalization: a tertiary referral center experience. J Heal Sci Med. 2022;5(6):1612–1618.
  • Duarte MCB, Becker GN, Muller GG, Tuon FF. Infectious keratitis in southern Brazil: a comparison culture negative and culture positive patients. Rev Bras Oftalmol. 2020;79(1):46–52.
  • Bhadange Y, Das S, Kasav MK, Sahu SK, Sharma S. Comparison of culture-negative and culture-positive microbial keratitis: cause of culture negativity, clinical features and final outcome. Br J Ophthalmol. 2015;99(11):1498–1502. doi:10.1136/bjophthalmol-2014-306414
  • Sharma S, Taneja M, Gupta R, et al. Comparison of clinical and microbiological profiles in smear-positive and smear-negative cases of suspected microbial keratitis. Indian J Ophthalmol. 2007;55(1):21–25. doi:10.4103/0301-4738.29490
  • Yarımada S, Selver ÖB, Palamar M, et al. Comparison of culture-positive and -negative microbial keratitis. Turkish J Ophthalmol. 2022;52(1):1–5. doi:10.4274/tjo.galenos.2021.98046
  • Fanselow N, Sirajuddin N, Yin XT, Huang AJW, Stuart PM. Acanthamoeba keratitis, pathology, diagnosis and treatment. Pathog. 2021;10(3):1–11. doi:10.3390/pathogens10030323
  • Lorenzo-Morales J, Khan NA, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite. 2015;22:10. doi:10.1051/parasite/2015010
  • Radhakrishnan N, Pathak N, Subramanian KR, et al. Comparative study on costs incurred for treatment of patients with bacterial and fungal keratitis - A retrospective analysis. Indian J Ophthalmol. 2022;70(4):1191. doi:10.4103/ijo.IJO_2176_21
  • Owens DK, Qaseem A, Chou R, Shekelle P. Clinical guideline high-value, cost-conscious health care: concepts for clinicians to evaluate the benefits, harms, and costs of medical interventions. Ann Intern Med. 2011;154(3):174–180. doi:10.7326/0003-4819-154-3-201102010-00007